PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced that Amir Avniel, president and chief executive officer, will be presenting a corporate update at the Rodman & Renshaw 11th Annual Healthcare Conference on Thursday, September 10, 2009 at 02:25 p.m., (Eastern Time) at the New York Palace Hotel in New York City.
